4.7 Article

Smoking Cessation Counseling Beliefs and Behaviors of Outpatient Oncology Providers

Journal

ONCOLOGIST
Volume 17, Issue 3, Pages 455-462

Publisher

WILEY
DOI: 10.1634/theoncologist.2011-0350

Keywords

Smoking cessation; Clinical oncology; Health care providers; Cancer

Categories

Funding

  1. Ameritox
  2. Archimedes Pharmaceuticals
  3. Boston Scientific
  4. Covidien Mallinckrodt Inc.
  5. Endo Pharmaceuticals
  6. Forest Labs
  7. K-Pax Pharmaceuticals
  8. Meda Pharmaceuticals
  9. Medtronics
  10. Otsuka Pharma
  11. ProStrakan
  12. Purdue Pharma
  13. Salix
  14. St. Jude Medical

Ask authors/readers for more resources

Purpose. Many cancer patients continue to smoke after diagnosis, increasing their risk for treatment complications, reduced treatment efficacy, secondary cancers, and reduced survival. Outpatient oncology providers may not be using the teachable moment of cancer diagnosis to provide smoking cessation assistance. Providers and Methods. Physicians and midlevel providers (n = 74) who provide outpatient oncology services completed an online survey regarding smoking cessation counseling behaviors, beliefs, and perceived barriers. Outpatient medical records for 120 breast, lung, head and neck, colon, prostate, and acute leukemia cancer patients were reviewed to assess current smoking cessation assessment and intervention documentation practices. Results. Providers reported commonly assessing smoking in new patients (82.4% frequently or always), but rates declined at subsequent visits for both current smokers and recent quitters. Rates of advising patients to quit smoking were also high (86.5% frequently or always), but < 30% of providers reported frequently or always providing intervention to smoking patients (e. g., nicotine replacement therapy or other medications, self-help materials, and/or referrals). Only 30% of providers reported that they frequently or always followed up with patients to assess progress with quitting. Few providers (18.1%) reported high levels of confidence in their ability to counsel smoking patients. Patients' lack of motivation was identified as the most important barrier to smoking cessation. Conclusions. Although beliefs about providing cessation services to smoking patients were generally positive, few providers reported commonly providing interventions beyond advice to quit. Additional training and clinic-based interventions may improve adherence to tobacco cessation practice guidelines in the outpatient oncology setting. The Oncologist 2012; 17: 455-462

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available